X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217230
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216549
https://www.expresspharma.in/lupin-receives-us-fda-approval-for-rufinamide-tablets/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204964
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213457
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211388
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207363
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207363
https://www.tga.gov.au/prescription-medicines-registration-new-chemical-entities-australia
https://www.pharmacompass.com/pdf/news/banzelrufinamide-eisai-co-v-bionpharma-1525071719.pdf
https://www.pharmacompass.com/pdf/news/roxanes-generic-rufinamide-approved-in-us-as-an-anticonvulsant-medication-1463569742.pdf
https://www.pharmacompass.com/pdf/news/glenmarks-generic-rufinamide-approved-in-us-as-an-anticonvulsant-medication-1463569696.pdf
https://www.pharmacompass.com/pdf/news/mylan-pharms-generic-rufinamide-approved-in-us-as-an-anticonvulsant-medication-1463569637.pdf
http://www.prnewswire.com/news-releases/presentados-nuevos-datos-de-practica-clinica-sobre-el-uso-de-zebinix-acetato-de-eslicarbazepina-para-tratar-las-crisis-de-inicio-parcial-en-la-reunion-anual-de-la-sociedad-americana-de-epilepsia-aes-561277221.html
http://www.prnewswire.com/news-releases/zebinix-acetate-deslicarbazepine-dans-la-prise-en-charge-des-crises-partielles-depilepsie-nouvelles-analyses-de-donnees-de-vie-reelle-presentees-lors-du-congres-annuel-de-lamerican-epilepsy-society-aes-560733251.html
http://www.prnewswire.com/news-releases/los-resultados-finales-del-estudio-epos-presentados-en-el-congreso-internacional-de-epilepsia-iec-muestran-que-el-tratamiento-adyuvante-con-zebinix-acetato-de-eslicarbazepina-mejora-la-calidad-de-vida-525801711.html
http://eisai.mediaroom.com/2015-04-30-Eisai-and-Glenmark-Reach-Settlement-over-Generic-Version-of-BANZEL-rufinamide
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/01/report-card-fda-gets-a-solid-b-on-timely-responding-to-section-505w-discontinuation-citizen-petition.html
Market Place
Share 
